Cristofanilli M - Search Results

1

GSK-3 inhibition overcomes chemoresistance in human breast cancer.

Ugolkov A, Gaisina I, Zhang JS, Billadeau DD, White K, Kozikowski A, Jain S, Cristofanilli M, Giles F, O'Halloran T, Cryns VL, Mazar AP. Ugolkov A, et al. Among authors: cristofanilli m. Cancer Lett. 2016 Oct 1;380(2):384-392. doi: 10.1016/j.canlet.2016.07.006. Epub 2016 Jul 14. Cancer Lett. 2016. PMID: 27424289 Free PMC article.

2

Novel targeted therapies in inflammatory breast cancer.

Cristofanilli M. Cristofanilli M. Cancer. 2010 Jun 1;116(11 Suppl):2837-9. doi: 10.1002/cncr.25172. Cancer. 2010. PMID: 20503416 Free article.

3

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.

Salem I, Alsalahi M, Chervoneva I, Aburto LD, Addya S, Ott GR, Ruggeri BA, Cristofanilli M, Fernandez SV. Salem I, et al. Among authors: cristofanilli m. Breast Cancer Res. 2016 Mar 24;18(1):37. doi: 10.1186/s13058-016-0694-4. Breast Cancer Res. 2016. PMID: 27009091 Free PMC article.

4

Inflammatory breast cancer: a new approach.

Cristofanilli M. Cristofanilli M. Lancet Oncol. 2016 May;17(5):544-6. doi: 10.1016/S1470-2045(16)00064-4. Epub 2016 Mar 28. Lancet Oncol. 2016. PMID: 27032300 No abstract available.

5

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.

Chae YK, Davis AA, Carneiro BA, Chandra S, Mohindra N, Kalyan A, Kaplan J, Matsangou M, Pai S, Costa R, Jovanovic B, Cristofanilli M, Platanias LC, Giles FJ. Chae YK, et al. Among authors: cristofanilli m. Oncotarget. 2016 Oct 4;7(40):65364-65373. doi: 10.18632/oncotarget.11692. Oncotarget. 2016. PMID: 27588476 Free PMC article.

6

Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.

Wang C, Mu Z, Chervoneva I, Austin L, Ye Z, Rossi G, Palazzo JP, Sun C, Abu-Khalaf M, Myers RE, Zhu Z, Ba Y, Li B, Hou L, Cristofanilli M, Yang H. Wang C, et al. Among authors: cristofanilli m. Breast Cancer Res Treat. 2017 Jan;161(1):83-94. doi: 10.1007/s10549-016-4026-2. Epub 2016 Oct 22. Breast Cancer Res Treat. 2017. PMID: 27771841

7

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials.

Costa R, Carneiro BA, Agulnik M, Rademaker AW, Pai SG, Villaflor VM, Cristofanilli M, Sosman JA, Giles FJ. Costa R, et al. Among authors: cristofanilli m. Oncotarget. 2017 Jan 31;8(5):8910-8920. doi: 10.18632/oncotarget.13315. Oncotarget. 2017. PMID: 27852042 Free PMC article. Review.

8

Metastatic breast cancer: focus on endocrine sensitivity.

Cristofanilli M. Cristofanilli M. Lancet. 2016 Dec 17;388(10063):2961-2962. doi: 10.1016/S0140-6736(16)32418-7. Epub 2016 Nov 29. Lancet. 2016. PMID: 27908455 No abstract available.

9

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Costa R, Santa-Maria CA, Rossi G, Carneiro BA, Chae YK, Gradishar WJ, Giles FJ, Cristofanilli M. Costa R, et al. Among authors: cristofanilli m. Oncotarget. 2017 Feb 14;8(7):12417-12432. doi: 10.18632/oncotarget.13778. Oncotarget. 2017. PMID: 27926493 Free PMC article. Review.

10

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.

Chae YK, Ranganath K, Hammerman PS, Vaklavas C, Mohindra N, Kalyan A, Matsangou M, Costa R, Carneiro B, Villaflor VM, Cristofanilli M, Giles FJ. Chae YK, et al. Among authors: cristofanilli m. Oncotarget. 2017 Feb 28;8(9):16052-16074. doi: 10.18632/oncotarget.14109. Oncotarget. 2017. PMID: 28030802 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters